Spyre Therapeutics (SYRE) Shares Issued (2017 - 2025)
Spyre Therapeutics' Shares Issued history spans 9 years, with the latest figure at $3.3 million for Q4 2025.
- For Q4 2025, Shares Issued rose 102.05% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, down 55.98%, while the annual FY2025 figure was $3.3 million, 55.98% down from the prior year.
- Shares Issued reached $3.3 million in Q4 2025 per SYRE's latest filing, up from -$161.3 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $164.0 million in Q3 2024 to a low of -$161.3 million in Q4 2024.
- Average Shares Issued over 5 years is $817428.6, with a median of $275500.0 recorded in 2021.
- The largest YoY upside for Shares Issued was 911016.67% in 2024 against a maximum downside of 39936.79% in 2024.
- A 5-year view of Shares Issued shows it stood at -$1.7 million in 2021, then surged by 102.3% to $38000.0 in 2022, then soared by 965.79% to $405000.0 in 2023, then crashed by 39936.79% to -$161.3 million in 2024, then skyrocketed by 102.05% to $3.3 million in 2025.
- Per Business Quant, the three most recent readings for SYRE's Shares Issued are $3.3 million (Q4 2025), -$161.3 million (Q4 2024), and $164.0 million (Q3 2024).